Nasdaq:US$17.92 (-0.64) | HKEX:HK$28.60 (-0.75) | AIM:£2.79 (-0.11)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma